{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "CASP7 (Caspase-7) physically binds and cleaves specific isoforms of ATXN3 (Co-IP evidence)",
  "functions": [
    {
      "function": "ATXN3 Proteolysis",
      "arrow": "activates",
      "cellular_process": "Apoptotic proteolytic processing",
      "effect_description": "Caspase-7 cleaves ATXN3 to generate truncated, highly toxic, and aggregation-prone C-terminal fragments.",
      "biological_consequence": [
        "Apoptotic stimulus → Activation of Caspase-7 → Recognition of DXXD motifs (D241/D244/D248) in ATXN3 → Proteolytic cleavage → Release of ~28-37 kDa C-terminal polyQ fragments → Enhanced nucleation and aggregate formation → Increased neurotoxicity."
      ],
      "specific_effects": [
        "Generation of ~28 kDa and ~37 kDa ATXN3 fragments",
        "Increased rate of SDS-insoluble aggregate formation",
        "Enhanced nuclear accumulation of polyQ-containing fragments"
      ],
      "evidence": [
        {
          "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
          "journal": "Journal of Neurochemistry",
          "year": 2004,
          "relevant_quote": "Caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis.",
          "pmid": "15140190"
        }
      ],
      "pmids": [
        "15140190"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "Confirmed: Caspase-7 (along with Caspase-1 and Caspase-3) cleaves ATXN3 at specific aspartate residues (D241, D244, and D248) located near the polyglutamine tract. This cleavage releases C-terminal fragments containing the expanded polyQ repeat, which are significantly more prone to aggregation and nuclear translocation than the full-length protein, thereby driving pathogenesis.",
  "mechanism": "Apoptotic proteolytic processing",
  "effect": "Caspase-7 cleaves ATXN3 to generate truncated, highly toxic, and aggregation-prone C-terminal fragments.",
  "summary": "ATXN3 activates CASP7 to modulate atxn3 proteolysis, ultimately affecting increased neurotoxicity.",
  "evidence": [
    {
      "paper_title": "Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3",
      "journal": "Journal of Neurochemistry",
      "year": 2004,
      "relevant_quote": "Caspase-mediated cleavage of expanded ataxin-3 resulted in increased ataxin-3 aggregation, suggesting a potential role for caspase-mediated proteolysis in spinocerebellar ataxia type-3 pathogenesis."
    }
  ],
  "initial_pathway": {
    "pathway_name": "Execution Phase of Apoptosis",
    "confidence": 0.9,
    "reasoning": "Caspase-7 (and Caspase-3) cleaves ATXN3, generating toxic fragments that promote cell death in neurodegenerative contexts."
  },
  "interaction_effect": "activates",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 3
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--activates-- CASP7:",
  "protein_a": "CASP7",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-21T04:04:27.489247Z",
  "last_updated": "2025-12-21T04:04:27.489247Z"
}